CHELSIVA
LIVE

Serial Number

99635470

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Feb 5, 2026

Add to watchlist:

No watchlists yet
View on USPTO

CHELSIVA Trademark

Serial Number: 99635470

CHELSIVA is a trademark filed by Novartis AG on February 5, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

February 5, 2026

Registration Date

Not Registered

Published for Opposition

April 14, 2026

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 14, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 14, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 8, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 16, 2026 CNSA
ASSIGNED TO EXAMINER
Mar 6, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 5, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 5, 2026 NWOS
NEW APPLICATION ENTERED
Feb 5, 2026 NWAP